HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yaozu Xiang Selected Research

Proteins (Proteins, Gene)

1/2022Genome-wide CRISPR-Cas9 screening identifies the CYTH2 host gene as a potential therapeutic target of influenza viral infection.
5/2015Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yaozu Xiang Research Topics

Disease

4Myocardial Infarction
01/2022 - 05/2009
2Heart Failure
01/2022 - 04/2021
2Ischemia
01/2022 - 04/2021
1Polyploidy
05/2022
1Congenital Heart Defects (Congenital Heart Defect)
05/2022
1Ventricular Remodeling
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Infections
01/2022
1Diabetes Mellitus
01/2022
1Human Influenza (Influenza)
01/2022
1Fetal Death
12/2021
1Heart Diseases (Heart Disease)
04/2021
1Hypoxia (Hypoxemia)
01/2021
1Myocardial Reperfusion Injury
01/2021
1Hypertension (High Blood Pressure)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Coronary Disease (Coronary Heart Disease)
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Cytokine Release Syndrome
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2018
1Reperfusion Injury
06/2018
1Stroke (Strokes)
05/2016
1Hemorrhage
05/2016
1Thrombotic Thrombocytopenic Purpura
05/2016
1von Willebrand Diseases (von Willebrand's Disease)
05/2016
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2016
1Leukemia
01/2016
1Hyperglycemia
05/2015
1Thrombosis (Thrombus)
05/2015
1Edema (Dropsy)
01/2012
1Inflammation (Inflammations)
01/2012
1Unstable Angina
01/2008

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2015
2Pharmaceutical PreparationsIBA
01/2022 - 04/2021
2von Willebrand FactorIBA
05/2016 - 05/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
05/2022
1Transcription Factors (Transcription Factor)IBA
05/2022
1Fatty Acids (Saturated Fatty Acids)IBA
05/2022
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2022
1SecinH3IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1N-acetylneuraminate synthaseIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1SaponinsIBA
04/2021
1MetalsIBA
01/2021
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021
1IridiumIBA
01/2021
1C-Reactive ProteinIBA
01/2020
1InflammasomesIBA
01/2019
1MicroRNAs (MicroRNA)IBA
06/2018
1Glycoproteins (Glycoprotein)IBA
05/2016
1thiamine triphosphorate (TTP)IBA
05/2016
1Rho Guanine Nucleotide Exchange FactorsIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
05/2015
1Aldehyde Reductase (Aldose Reductase)IBA
05/2015
1Messenger RNA (mRNA)IBA
05/2015
1CarrageenanIBA
01/2012
1genipinIBA
01/2012
1Therapeutic UsesIBA
05/2009
1Nonprescription Drugs (Patent Medicines)IBA
05/2009

Therapy/Procedure

3Therapeutics
05/2022 - 05/2009
2Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2009 - 01/2008
1Ligation
04/2021
1Secondary Prevention
05/2009